Merocets 1.4mg Lozenges

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Cetylpyridinium chloride

から入手可能:

Sanofi-Aventis Ireland Limited T/A SANOFI

ATCコード:

R02AA; R02AA06

INN（国際名）:

Cetylpyridinium chloride

投薬量:

1.4 milligram(s)

医薬品形態:

Lozenge

処方タイプ:

Product not subject to medical prescription

治療領域:

Antiseptics; cetylpyridinium

認証ステータス:

Not marketed

承認日:

1988-07-25

情報リーフレット

PATIENT INFORMATION LEAFLET
MEROCETS 1.4MG LOZENGES
_Cetylpyridinium chloride _
IS THIS LEAFLET HARD TO SEE OR READ? PHONE [phone] FOR HELP
Read all of this leaflet carefully before you starting taking this
medicine.
because it contains important information for you.
Always take this medicine exactly as described in this leaflet or as
your doctor
or pharmacist or nurse has told you.
•
Keep this leaflet. You may need to read it again.
•
Ask your pharmacist if you need more information or advice.
•
If you get any side effects, talk to your doctor or pharmacist or
nurse.
This includes any possible side effects not listed in this leaflet.
See
section 4.
•
You must talk to a doctor if you do not feel better or if you feel
worse
after three days.
WHAT IS IN THIS LEAFLET
1.
What Merocets are and what they are used used for
2.
What you need to know before you take Merocets
3.
How to take Merocets
4.
Possible side effects
5.
How to store Merocets
6.
Contents of the pack and other information
1. WHAT MEROCETS ARE AND WHAT THEY ARE USED FOR
These lozenges are used for the symptomatic relief of sore throats and
other
symptoms associated with minor irritations of the mouth and throat.
Cetylpyridinium chloride has antiseptic properties.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MEROCETS
DO NOT TAKE MEROCETS AND TELL YOUR DOCTOR
•
If you are allergic to any of the ingredients in this product. See
section
6.
WARNINGS AND PRECAUTIONS
TAKE SPECIAL CARE AND CHECK WITH YOUR DOCTOR OR PHARMACIST
•
If you develop a fever or your sore throat worsens or persists for
more
than three days consult your doctor.
•
If you suffer from diabetes mellitus, take into account the
carbohydrate
content.
TAKING OTHER MEDICINES
Please tell your doctor or pharmacist if you are taking or have
recently taken
any other medicines. This includes medicines obtained without a
prescription,
including herbal medicines. This is because Merocets can affect the
way
some other medicines work. Also, some other medicines can affect the
way
Merocets wor

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Merocets 1.4mg Lozenges
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each lozenge contains: Cetylpyridinium chloride 1.4mg.
Excipients: Also contains sucrose 1139.2mg, glucose liquid 1314.5mg
and sunset yellow (E110) 0.0036mg.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Lozenge
Round, yellow, plain, convex lozenges.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As an antiseptic for the symptomatic relief of sore throat. Also
indicated for the minor irritations of the mouth and
throat.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For oral administration
ADULTS, THE ELDERLY AND CHILDREN OVER 6 YEARS:
One lozenge every 3 hours. Allow the lozenge to dissolve slowly in the
mouth.
CHILDREN UNDER 6 YEARS: not recommended
4.3 CONTRAINDICATIONS
Hypersensitivity to the active ingredient cetylpyridinium chloride or
to any other excipients in this product listed in
section 6.1.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Consult your doctor in case of severe irritation of your throat with
high fever or if symptoms persist for more than 3
days.
Advice for diabetic patients:
Take into account the carbohydrate content.
Merocets contains sucrose and glucose. Patients with rare hereditary
problems of fructose intolerance, glucose-
galactose malabsorption or sucrase-isomaltase insufficiency should not
take this medicine.
Sunset yellow (E110) may cause allergic reactions.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_